Azevedo Guerreiro Rui, Fernandes Renato, Campante Teles Rui, Canas da Silva Pedro, Pereira Hélder, Cruz Ferreira Rui, Costa Marco, Seixo Filipe, Farto E Abreu Pedro, Pipa João Luís, Bernardes Luís, Pereira Machado Francisco, Palos José, Infante de Oliveira Eduardo, Cyrne Carvalho Henrique, Silva João Carlos, Caires Graça, Martins Dinis, Baptista José, Calisto João, Pontes Dos Santos Rui, Matias Fernando, Costa João, Sousa Paulino, Gama Ribeiro Vasco, Fiarresga António, Brum da Silveira João
Hospital do Espírito Santo EPE, Évora, Portugal.
Hospital do Espírito Santo EPE, Évora, Portugal.
Rev Port Cardiol (Engl Ed). 2019 Nov;38(11):779-785. doi: 10.1016/j.repc.2019.02.007. Epub 2020 Feb 11.
Coronary intravascular ultrasound (IVUS) is increasingly important in catheterization laboratories due to its positive prognostic impact. This study aims to characterize the use of IVUS in percutaneous coronary intervention (PCI) in Portugal.
A retrospective observational study was performed based on the Portuguese Registry on Interventional Cardiology of the Portuguese Society of Cardiology. The clinical and angiographic profiles of patients who underwent PCI between 2002 and 2016, the percentage of IVUS use, and the coronary arteries assessed were characterized.
A total of 118 706 PCIs were included, in which IVUS was used in 2266 (1.9%). Over time, use of IVUS changed from none in 2002 to generally increasing use from 2003 (0.1%) to 2016 (2.4%). The age of patients in whom coronary IVUS was used was similar to that of patients in whom IVUS was not used, but in the former group there were fewer male patients, and a higher prevalence of cardiovascular risk factors (hypertension, hypercholesterolemia and diabetes), previous myocardial infarction, previous PCI, multivessel coronary disease, C-type or bifurcated coronary lesions, and in-stent restenosis. IVUS was used in 54.8% of elective PCIs and in 19.15% of PCIs of the left main coronary artery.
Coronary IVUS has been increasingly used in Portugal since 2003. It is used preferentially in elective PCIs, and in patients with higher cardiovascular risk, with more complex coronary lesions and lesions of the left main coronary artery.
冠状动脉血管内超声(IVUS)因其对预后有积极影响,在导管实验室中变得越来越重要。本研究旨在描述葡萄牙经皮冠状动脉介入治疗(PCI)中IVUS的使用情况。
基于葡萄牙心脏病学会介入心脏病学登记处进行了一项回顾性观察研究。对2002年至2016年间接受PCI的患者的临床和血管造影特征、IVUS使用百分比以及评估的冠状动脉进行了描述。
共纳入118706例PCI,其中2266例(1.9%)使用了IVUS。随着时间推移,IVUS的使用从2002年的无使用变为从2003年(0.1%)到2016年(2.4%)普遍增加。使用冠状动脉IVUS的患者年龄与未使用IVUS的患者相似,但前一组男性患者较少,心血管危险因素(高血压、高胆固醇血症和糖尿病)、既往心肌梗死、既往PCI、多支冠状动脉疾病、C型或分叉冠状动脉病变以及支架内再狭窄的患病率较高。IVUS在54.8%的择期PCI和19.15%的左主干冠状动脉PCI中使用。
自2003年以来,冠状动脉IVUS在葡萄牙的使用越来越多。它优先用于择期PCI以及心血管风险较高、冠状动脉病变更复杂和左主干冠状动脉病变的患者。